The Immune Checkpoint ICOSLG is a Relapse-Predicting Biomarker and Therapeutic Target in Infant t(4;11) Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Immune Checkpoint ICOSLG is a Relapse-Predicting Biomarker and Therapeutic Target in Infant t(4;11) Acute Lymphoblastic Leukemia

Published:2022 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Külp Marius,Siemund Anna Lena,Larghero Patrizia,Dietz Alissa,Alten Julia,Cario Gunnar,Eckert Cornelia,Caye-Eude Aurelie,Cavé Helene,Bardini Michela,Cazzaniga Giovanni,De Lorenzo Paola,Valsecchi Maria Grazia,Diehl Laura,Halvard Bonig,Meyer Claus,Marschalek Rolf

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference85 articles.

1. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis;A Agraz-Doblas;Haematologica,2019

2. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity;O Akbari;Nature Medicine,2002

3. Regulatory T cells mediate maternal tolerance to the fetus';V R Aluvihare;Nature Immunology,2004

4. Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance;P O Anderson;European Journal of Immunology,2006

5. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias;A K Andersson;Nature Genetics,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP